Comprehensive analysis of mechanism underlying hypouricemic effect of glucosyl hesperidin

Hyperuricemia is caused by hepatic overproduction of uric acid and/or underexcretion of urate from the kidneys and small intestine. Although increased intake of citrus fruits, a fructose-rich food, is associated with increased risk of gout in humans, hesperidin, a flavonoid naturally present in citr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 2020-01, Vol.521 (4), p.861-867
Hauptverfasser: Ota-Kontani, Ami, Hirata, Hiroshi, Ogura, Masatsune, Tsuchiya, Youichi, Harada-Shiba, Mariko
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 867
container_issue 4
container_start_page 861
container_title Biochemical and biophysical research communications
container_volume 521
creator Ota-Kontani, Ami
Hirata, Hiroshi
Ogura, Masatsune
Tsuchiya, Youichi
Harada-Shiba, Mariko
description Hyperuricemia is caused by hepatic overproduction of uric acid and/or underexcretion of urate from the kidneys and small intestine. Although increased intake of citrus fruits, a fructose-rich food, is associated with increased risk of gout in humans, hesperidin, a flavonoid naturally present in citrus fruits, reportedly reduces serum uric acid (SUA) levels by inhibiting xanthine oxidase (XOD) activity in rats. However, the effects of hesperidin on renal and intestinal urate excretion were previously unknown. In this study, we used glucosyl hesperidin (GH), which has greater bioavailability than hesperidin, to clarify comprehensive mechanisms underlying the hypouricemic effects of hesperidin in vivo. GH dose-dependently decreased SUA levels in mice with hyperuricemia induced by potassium oxonate and a fructose-rich diet, and inhibited XOD activity in the liver. GH decreased renal urate excretion without changes in kidney URAT1, ABCG2 or GLUT9 expressions, suggesting that reducing uric acid pool size by inhibiting XOD decreased renal urate excretion. We also found that GH had no effect on intestinal urate excretion or protein expression of ABCG2. Therefore, we concluded that GH exhibits a hypouricemic effect by inhibiting XOD activity in the liver without increasing renal or intestinal urate excretion. Of note, this is the first study to elucidate the effect of a flavonoid on intestinal urate excretion using a mice model, whose findings should prove useful in future food science research in the area of urate metabolism. Taking these findings together, GH may be useful for preventing hyperuricemia, especially in people with the overproduction type. •Glucosyl hesperidin decreased serum uric acid level in hyperuricemia mice.•Glucosyl hesperidin inhibited liver xanthine oxidase activity but did not affect renal or extrarenal urate metabolism.•Glucosyl hesperidin should help prevent hyperuricemia, especially the type with increased uric acid production.
doi_str_mv 10.1016/j.bbrc.2019.10.199
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2314036067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X19321151</els_id><sourcerecordid>2314036067</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-4fc7d6c5f7311a1d305ef90eacc2fe5f52b75cd6764bde612f768d14d826f4a13</originalsourceid><addsrcrecordid>eNp9kEtLxDAUhYMoOo7-ARfSpZuOuWmaGnAjgy8Q3CjoKqTJzUyGvkymQv-9raMuXV04fOfA_Qg5A7oACuJysyjLYBaMglxMmZR7ZAZU0pQB5ftkRikVKZPwdkSOY9xQCsCFPCRHGRQAghcz8r5s6y7gGpvoPzHRja6G6GPSuqRGs9aNj3XSNxZDNfhmlayHru2DN1h7k6BzaLYTu6p608ahStYYOwze-uaEHDhdRTz9uXPyenf7snxIn57vH5c3T6nhjG1T7kxhhcldkQFosBnN0UmK2hjmMHc5K4vcWFEIXloUwFwhrixwe8WE4xqyObnY7Xah_egxblXto8Gq0g22fVQsA04zQUUxomyHmtDGGNCpLvhah0EBVZNStVGTUjUp_c6kHEvnP_t9WaP9q_w6HIHrHYDjl58eg4rGY2PQ-jDqUbb1_-1_AUqTidI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2314036067</pqid></control><display><type>article</type><title>Comprehensive analysis of mechanism underlying hypouricemic effect of glucosyl hesperidin</title><source>Elsevier ScienceDirect Journals</source><creator>Ota-Kontani, Ami ; Hirata, Hiroshi ; Ogura, Masatsune ; Tsuchiya, Youichi ; Harada-Shiba, Mariko</creator><creatorcontrib>Ota-Kontani, Ami ; Hirata, Hiroshi ; Ogura, Masatsune ; Tsuchiya, Youichi ; Harada-Shiba, Mariko</creatorcontrib><description>Hyperuricemia is caused by hepatic overproduction of uric acid and/or underexcretion of urate from the kidneys and small intestine. Although increased intake of citrus fruits, a fructose-rich food, is associated with increased risk of gout in humans, hesperidin, a flavonoid naturally present in citrus fruits, reportedly reduces serum uric acid (SUA) levels by inhibiting xanthine oxidase (XOD) activity in rats. However, the effects of hesperidin on renal and intestinal urate excretion were previously unknown. In this study, we used glucosyl hesperidin (GH), which has greater bioavailability than hesperidin, to clarify comprehensive mechanisms underlying the hypouricemic effects of hesperidin in vivo. GH dose-dependently decreased SUA levels in mice with hyperuricemia induced by potassium oxonate and a fructose-rich diet, and inhibited XOD activity in the liver. GH decreased renal urate excretion without changes in kidney URAT1, ABCG2 or GLUT9 expressions, suggesting that reducing uric acid pool size by inhibiting XOD decreased renal urate excretion. We also found that GH had no effect on intestinal urate excretion or protein expression of ABCG2. Therefore, we concluded that GH exhibits a hypouricemic effect by inhibiting XOD activity in the liver without increasing renal or intestinal urate excretion. Of note, this is the first study to elucidate the effect of a flavonoid on intestinal urate excretion using a mice model, whose findings should prove useful in future food science research in the area of urate metabolism. Taking these findings together, GH may be useful for preventing hyperuricemia, especially in people with the overproduction type. •Glucosyl hesperidin decreased serum uric acid level in hyperuricemia mice.•Glucosyl hesperidin inhibited liver xanthine oxidase activity but did not affect renal or extrarenal urate metabolism.•Glucosyl hesperidin should help prevent hyperuricemia, especially the type with increased uric acid production.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/j.bbrc.2019.10.199</identifier><identifier>PMID: 31711647</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Glucosyl hesperidin ; Hyperuricemia ; Xanthine oxidase</subject><ispartof>Biochemical and biophysical research communications, 2020-01, Vol.521 (4), p.861-867</ispartof><rights>2019 Elsevier Inc.</rights><rights>Copyright © 2019 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-4fc7d6c5f7311a1d305ef90eacc2fe5f52b75cd6764bde612f768d14d826f4a13</citedby><cites>FETCH-LOGICAL-c422t-4fc7d6c5f7311a1d305ef90eacc2fe5f52b75cd6764bde612f768d14d826f4a13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006291X19321151$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31711647$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ota-Kontani, Ami</creatorcontrib><creatorcontrib>Hirata, Hiroshi</creatorcontrib><creatorcontrib>Ogura, Masatsune</creatorcontrib><creatorcontrib>Tsuchiya, Youichi</creatorcontrib><creatorcontrib>Harada-Shiba, Mariko</creatorcontrib><title>Comprehensive analysis of mechanism underlying hypouricemic effect of glucosyl hesperidin</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>Hyperuricemia is caused by hepatic overproduction of uric acid and/or underexcretion of urate from the kidneys and small intestine. Although increased intake of citrus fruits, a fructose-rich food, is associated with increased risk of gout in humans, hesperidin, a flavonoid naturally present in citrus fruits, reportedly reduces serum uric acid (SUA) levels by inhibiting xanthine oxidase (XOD) activity in rats. However, the effects of hesperidin on renal and intestinal urate excretion were previously unknown. In this study, we used glucosyl hesperidin (GH), which has greater bioavailability than hesperidin, to clarify comprehensive mechanisms underlying the hypouricemic effects of hesperidin in vivo. GH dose-dependently decreased SUA levels in mice with hyperuricemia induced by potassium oxonate and a fructose-rich diet, and inhibited XOD activity in the liver. GH decreased renal urate excretion without changes in kidney URAT1, ABCG2 or GLUT9 expressions, suggesting that reducing uric acid pool size by inhibiting XOD decreased renal urate excretion. We also found that GH had no effect on intestinal urate excretion or protein expression of ABCG2. Therefore, we concluded that GH exhibits a hypouricemic effect by inhibiting XOD activity in the liver without increasing renal or intestinal urate excretion. Of note, this is the first study to elucidate the effect of a flavonoid on intestinal urate excretion using a mice model, whose findings should prove useful in future food science research in the area of urate metabolism. Taking these findings together, GH may be useful for preventing hyperuricemia, especially in people with the overproduction type. •Glucosyl hesperidin decreased serum uric acid level in hyperuricemia mice.•Glucosyl hesperidin inhibited liver xanthine oxidase activity but did not affect renal or extrarenal urate metabolism.•Glucosyl hesperidin should help prevent hyperuricemia, especially the type with increased uric acid production.</description><subject>Glucosyl hesperidin</subject><subject>Hyperuricemia</subject><subject>Xanthine oxidase</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kEtLxDAUhYMoOo7-ARfSpZuOuWmaGnAjgy8Q3CjoKqTJzUyGvkymQv-9raMuXV04fOfA_Qg5A7oACuJysyjLYBaMglxMmZR7ZAZU0pQB5ftkRikVKZPwdkSOY9xQCsCFPCRHGRQAghcz8r5s6y7gGpvoPzHRja6G6GPSuqRGs9aNj3XSNxZDNfhmlayHru2DN1h7k6BzaLYTu6p608ahStYYOwze-uaEHDhdRTz9uXPyenf7snxIn57vH5c3T6nhjG1T7kxhhcldkQFosBnN0UmK2hjmMHc5K4vcWFEIXloUwFwhrixwe8WE4xqyObnY7Xah_egxblXto8Gq0g22fVQsA04zQUUxomyHmtDGGNCpLvhah0EBVZNStVGTUjUp_c6kHEvnP_t9WaP9q_w6HIHrHYDjl58eg4rGY2PQ-jDqUbb1_-1_AUqTidI</recordid><startdate>20200122</startdate><enddate>20200122</enddate><creator>Ota-Kontani, Ami</creator><creator>Hirata, Hiroshi</creator><creator>Ogura, Masatsune</creator><creator>Tsuchiya, Youichi</creator><creator>Harada-Shiba, Mariko</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200122</creationdate><title>Comprehensive analysis of mechanism underlying hypouricemic effect of glucosyl hesperidin</title><author>Ota-Kontani, Ami ; Hirata, Hiroshi ; Ogura, Masatsune ; Tsuchiya, Youichi ; Harada-Shiba, Mariko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-4fc7d6c5f7311a1d305ef90eacc2fe5f52b75cd6764bde612f768d14d826f4a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Glucosyl hesperidin</topic><topic>Hyperuricemia</topic><topic>Xanthine oxidase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ota-Kontani, Ami</creatorcontrib><creatorcontrib>Hirata, Hiroshi</creatorcontrib><creatorcontrib>Ogura, Masatsune</creatorcontrib><creatorcontrib>Tsuchiya, Youichi</creatorcontrib><creatorcontrib>Harada-Shiba, Mariko</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ota-Kontani, Ami</au><au>Hirata, Hiroshi</au><au>Ogura, Masatsune</au><au>Tsuchiya, Youichi</au><au>Harada-Shiba, Mariko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comprehensive analysis of mechanism underlying hypouricemic effect of glucosyl hesperidin</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2020-01-22</date><risdate>2020</risdate><volume>521</volume><issue>4</issue><spage>861</spage><epage>867</epage><pages>861-867</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>Hyperuricemia is caused by hepatic overproduction of uric acid and/or underexcretion of urate from the kidneys and small intestine. Although increased intake of citrus fruits, a fructose-rich food, is associated with increased risk of gout in humans, hesperidin, a flavonoid naturally present in citrus fruits, reportedly reduces serum uric acid (SUA) levels by inhibiting xanthine oxidase (XOD) activity in rats. However, the effects of hesperidin on renal and intestinal urate excretion were previously unknown. In this study, we used glucosyl hesperidin (GH), which has greater bioavailability than hesperidin, to clarify comprehensive mechanisms underlying the hypouricemic effects of hesperidin in vivo. GH dose-dependently decreased SUA levels in mice with hyperuricemia induced by potassium oxonate and a fructose-rich diet, and inhibited XOD activity in the liver. GH decreased renal urate excretion without changes in kidney URAT1, ABCG2 or GLUT9 expressions, suggesting that reducing uric acid pool size by inhibiting XOD decreased renal urate excretion. We also found that GH had no effect on intestinal urate excretion or protein expression of ABCG2. Therefore, we concluded that GH exhibits a hypouricemic effect by inhibiting XOD activity in the liver without increasing renal or intestinal urate excretion. Of note, this is the first study to elucidate the effect of a flavonoid on intestinal urate excretion using a mice model, whose findings should prove useful in future food science research in the area of urate metabolism. Taking these findings together, GH may be useful for preventing hyperuricemia, especially in people with the overproduction type. •Glucosyl hesperidin decreased serum uric acid level in hyperuricemia mice.•Glucosyl hesperidin inhibited liver xanthine oxidase activity but did not affect renal or extrarenal urate metabolism.•Glucosyl hesperidin should help prevent hyperuricemia, especially the type with increased uric acid production.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31711647</pmid><doi>10.1016/j.bbrc.2019.10.199</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-291X
ispartof Biochemical and biophysical research communications, 2020-01, Vol.521 (4), p.861-867
issn 0006-291X
1090-2104
language eng
recordid cdi_proquest_miscellaneous_2314036067
source Elsevier ScienceDirect Journals
subjects Glucosyl hesperidin
Hyperuricemia
Xanthine oxidase
title Comprehensive analysis of mechanism underlying hypouricemic effect of glucosyl hesperidin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T07%3A44%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comprehensive%20analysis%20of%20mechanism%20underlying%20hypouricemic%20effect%20of%20glucosyl%20hesperidin&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Ota-Kontani,%20Ami&rft.date=2020-01-22&rft.volume=521&rft.issue=4&rft.spage=861&rft.epage=867&rft.pages=861-867&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/j.bbrc.2019.10.199&rft_dat=%3Cproquest_cross%3E2314036067%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2314036067&rft_id=info:pmid/31711647&rft_els_id=S0006291X19321151&rfr_iscdi=true